Latest Intelligence
US pharmacy groups propose new sourcing rules for six peptide APIs
Divi's expands peptide synthesis with new 3,000-litre lines
Hanyu advances plan to double Wuhan peptide capacity
Neuland outlines timeline for peptide manufacturing ramp-up
Canada seizes more than 11,400 vials in peptide import crackdown
Featured Analysis
Samsung's peptide ambitions: Why the Korean giant is betting $1.8 billion on PolyPeptide
Samsung has spent the past decade proving it can turn pharmaceutical manufacturing into an industrial powerhouse. Now it's bringing that ambition — and its financial firepower — to peptides.
READ THE ANALYSIS →